Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation-Reference-Cited by-同舟云学术

Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation

Published:2017-01-17 Issue:11 Volume:47 Page:1147-1154
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Honda Masaki¹,Sugawara Yasuhiko¹,Watanabe Takehisa²,Tateyama Masakuni²,Tanaka Motohiko²,Uchida Koushi¹,Kawabata Seiichi¹,Yoshii Daiki¹,Miura Kouhei¹,Isono Kaori¹,Hayashida Shintaro¹,Ohya Yuki¹,Yamamoto Hidekazu¹,Sasaki Yutaka²,Inomata Yukihiro¹

Affiliation:

1. Departments of Transplantation/Pediatric Surgery

2. Gastroenterology and Hepatology; Postgraduate School of Life Science, Kumamoto University; Kumamoto Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12853/fullpdf

Reference43 articles.

1. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation;Berenguer;Hepatology,2000

2. Recurrent and acquired hepatitis C viral infection in liver transplant recipients;Wright;Gastroenterology,1992

3. The natural history of hepatitis C cirrhosis after liver transplantation;Firpi;Liver Transpl,2009

4. Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

5. Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis;Transplant Infectious Disease;2019-01-21

2. Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents;Journal of Gastrointestinal Surgery;2018-04-20